• Tue, October 31, 2023

by: WOPRAI

Jeff Cantwell Initiated (TOST) at Sell and Held Target at $16 on, Oct 31st, 2023

by: WOPRAI

Ben Hendrix Maintained (THC) at Buy with Decreased Target to $72 on, Oct 31st, 2023

by: WOPRAI

Ann Hynes Maintained (THC) at Strong Buy with Decreased Target to $77 on, Oct 31st, 2023

by: WOPRAI

Ketan Mamtora Maintained (TREX) at Hold with Increased Target to $72 on, Oct 31st, 2023

by: WOPRAI

Reuben Garner Reiterated (TREX) at Strong Buy and Held Target at $85 on, Oct 31st, 2023

by: WOPRAI

Yatin Suneja Initiated (trml) at Strong Buy and Held Target at $50 on, Oct 31st, 2023

by: WOPRAI

Chris Allen Upgraded (TROW) to Hold and Decreased Target to $95 on, Oct 31st, 2023

by: WOPRAI

Toni Kaplan Maintained (TRU) at Hold with Decreased Target to $63 on, Oct 31st, 2023

by: WOPRAI

Edward Kelly Maintained (SYY) at Buy and Held Target at $80 on, Oct 31st, 2023

by: WOPRAI

Jake Bartlett Maintained (SYY) at Strong Buy and Held Target at $87 on, Oct 31st, 2023

by: WOPRAI

Dana Telsey Reiterated (TDUP) at Buy and Held Target at $4 on, Oct 31st, 2023

by: WOPRAI

Matthew McKellar Downgraded (CLW) to Hold on, Oct 31st, 2023

by: WOPRAI

Arvind Ramnani Maintained (CHGG) at Hold with Decreased Target to $9 on, Oct 31st, 2023

by: WOPRAI

Jeffrey Silber Maintained (CHGG) at Hold with Decreased Target to $10 on, Oct 31st, 2023

by: WOPRAI

Eric Sheridan Maintained (CHGG) at Hold with Decreased Target to $10 on, Oct 31st, 2023

by: WOPRAI

Doug Anmuth Maintained (CHGG) at Hold with Decreased Target to $10 on, Oct 31st, 2023

by: WOPRAI

Eric Serotta Initiated (CELH) at Hold and Held Target at $63 on, Oct 31st, 2023

by: WOPRAI

David Feaster Maintained (CCB) at Strong Buy with Decreased Target to $53 on, Oct 31st, 2023

by: WOPRAI

Duffy Fischer Maintained (CC) at Hold with Decreased Target to $30 on, Oct 31st, 2023

by: WOPRAI

Gil Blum Maintained (SRPT) at Strong Buy with Decreased Target to $82 on, Oct 31st, 2023

by: WOPRAI

Matthew Harrison Maintained (SRPT) at Buy with Decreased Target to $146 on, Oct 31st, 2023

by: WOPRAI

Kristen Kluska Downgraded (SRPT) to Hold and Decreased Target to $40 on, Oct 31st, 2023

by: WOPRAI

Brian Abrahams Maintained (SRPT) at Buy with Decreased Target to $148 on, Oct 31st, 2023

by: WOPRAI

Anupam Rama Maintained (SRPT) at Buy with Decreased Target to $115 on, Oct 31st, 2023

by: WOPRAI

Jeff Cantwell Initiated (SQ) at Hold and Held Target at $45 on, Oct 31st, 2023

by: WOPRAI

Carlos De Alba Maintained (STLD) at Hold with Increased Target to $108 on, Oct 31st, 2023

by: WOPRAI

Tristan Gerra Downgraded (STM) to Hold and Decreased Target to $35 on, Oct 31st, 2023

by: WOPRAI

William Crow Maintained (STAG) at Buy with Decreased Target to $37 on, Oct 31st, 2023

by: WOPRAI

Simon Yarmak Maintained (SPG) at Strong Buy with Decreased Target to $130 on, Oct 31st, 2023

by: WOPRAI

Jeffrey Adelson Upgraded (SOFI) to Hold and Held Target at $7 on, Oct 31st, 2023

by: WOPRAI

Andrew Jeffrey Maintained (SOFI) at Strong Buy with Decreased Target to $14 on, Oct 31st, 2023

by: WOPRAI

Stephanie Moore Upgraded (XPO) to Strong Buy and Increased Target to $95 on, Oct 31st, 2023

by: WOPRAI

Jack Atkins Maintained (XPO) at Hold with Increased Target to $86 on, Oct 31st, 2023

by: WOPRAI

Ravi Shanker Maintained (XPO) at Hold with Increased Target to $70 on, Oct 31st, 2023

by: WOPRAI

Fadi Chamoun Maintained (XPO) at Buy with Increased Target to $100 on, Oct 31st, 2023

by: WOPRAI

Christopher Kuhn Maintained (XPO) at Strong Buy with Increased Target to $90 on, Oct 31st, 2023

by: WOPRAI

Bascome Majors Maintained (XPO) at Buy with Increased Target to $92 on, Oct 31st, 2023

by: WOPRAI

Brian Ossenbeck Maintained (XPO) at Buy with Decreased Target to $88 on, Oct 31st, 2023

by: WOPRAI

C. Gregory Peters Maintained (WTW) at Buy with Increased Target to $255 on, Oct 31st, 2023

by: WOPRAI

Christopher Stathoulopoulos Maintained (ULCC) at Hold with Decreased Target to $4 on, Oct 31st, 2023

by: WOPRAI

Alexander Goldfarb Downgraded (UDR) to Sell and Decreased Target to $30 on, Oct 31st, 2023

by: WOPRAI

Joshua Dennerlein Downgraded (UDR) to Hold and Decreased Target to $33 on, Oct 31st, 2023

by: WOPRAI

Michael Phillips Maintained (ACGL) at Buy with Increased Target to $103 on, Oct 31st, 2023

by: WOPRAI

Matthew Carletti Reiterated (ACGL) at Buy and Held Target at $95 on, Oct 31st, 2023

by: WOPRAI

Jimmy Bhullar Maintained (ACGL) at Hold with Increased Target to $86 on, Oct 31st, 2023

by: WOPRAI

Laura Martin Reiterated (AAPL) at Strong Buy and Held Target at $195 on, Oct 31st, 2023

by: WOPRAI

Rajat Gupta Upgraded (ABG) to Buy and Decreased Target to $245 on, Oct 31st, 2023

by: WOPRAI

James Lee Maintained (ABNB) at Hold with Decreased Target to $130 on, Oct 31st, 2023

Matthew Harrison Maintained (SRPT) at Buy with Decreased Target to $146 on, Oct 31st, 2023

Matthew Harrison of Morgan Stanley, Maintained "Sarepta Therapeutics, Inc." (SRPT) at Buy with Decreased Target from $183 to $146 on, Oct 31st, 2023.

Matthew has made no other calls on SRPT in the last 4 months.



There is 1 other peer that has a rating on SRPT. Out of the 1 peers that are also analyzing SRPT, 0 agree with Matthew's Rating of Hold.



This is the rating of the analyst that currently disagrees with Matthew

  • Uy Ear of "Mizuho" Reiterated at Strong Buy and Held Target at $160 on, Tuesday, September 26th, 2023

Like: 👍